AKASA

AKASA is a remote company based in San Francisco. But even though we live all over the country, we still get together for fun virtual and in-person events. Last week, AKASAns gathered on Zoom to 🌱 build terrariums, 🕯️ melt candles, 🍵 drink tea, 🖌️ paint mandalas, 🌿 plant herbs, and 🛸 compete in Star Wars trivia. Lots of summertime team bonding and laughter.

"GenAI is a magical tool that can help us be substantially more efficient and comprehensive. But having humans work together with GenAI is critical." Read Integrated Healthcare Executive's Q&A with AKASA CEO and co-founder Malinka Walaliyadde and learn: 🤖 Why generative AI is important for the revenue cycle 📈 How leading health systems are using it — and the results they're seeing 🚫 Pitfalls to avoid when implementing this technology 🤯 How it helps reduce staff burnout 🧠 Why you need to train the technology on your data

We couldn't be more excited by what's happening with generative AI right now. And the innovation it's bringing to healthcare. Thanks, AIM Research, for including us in your list.

💡 Want to know what Stanford Health Care thinks about generative AI and how it's implementing this technology in the revenue cycle? Don't miss this Becker's Healthcare webinar. Thursday, July 18 at 12 p.m. CT Noel Juaire, Vice President of Patient Financial Services at Stanford Health Care, and Cory Costley, Chief Product Officer at AKASA, will discuss what this advanced technology means for the revenue cycle and why you should invest in it today. Learn more about: 🤖 What generative AI is and why the revenue cycle needs it 🧠 How Stanford thinks about the adoption of technology within their organization ✅ What the key KPIs and considerations are with implementing AI-based solutions inside a health system Don't miss out. Register now: https://lnkd.in/e3e-jqMb

🤯 “If you want to see a physician go apoplectic at a cocktail party, mention prior authorizations,” said Dr. Robert Wachter, the chair of the medicine department at the University of California, San Francisco. 🥊 Auth continues to be one of the biggest struggles in the healthcare revenue cycle space. That's one of the main reasons we developed Authorization Advisor. 💡 Like the vendors the NY Times interviewed in this story, we're using the latest in AI to improve the administrative complexities of this process. Authorization Advisor is a generative AI-powered assistant that helps prior auth specialists efficiently submit auth requests on payer portals. ➡️ See our AI in action: https://lnkd.in/eQG3nHeR

Is generative AI the future of medical coding? Here's what one director of mid-cycle thinks...

We’re proud to announce we’ve been recognized as a Great Place To Work for the 4️⃣th year in a row! 🎉 Earning this recognition is a testament to the supportive culture we’ve worked hard to establish at AKASA. ❤️ Thank you to all of our incredible employees. ❤️ Great Place To Work US

Want to talk about improving the revenue cycle with GenAI? So do we! Swing by the AKASA booth at HFMA and chat with some awesome folks. We're right when you walk in 👋 Take a break from the conference with some AI-powered putting while you're there. ⛳ Atticus Lynch Kelly Leo Amy Raymond Christian Carlson Betty Wei Linsey Morningstar Rick Tillar Justin Barlow Healthcare Financial Management Association (HFMA)

🎲 Are you in Vegas at HFMA? 🎲 What are you doing Tuesday at 9:50 a.m. PT? The correct answer is attending the Johns Hopkins Medicine and AKASA session on generative AI and the revenue cycle in Mandalay F. Lakmini Kidder, Vice President of Revenue Cycle Management at Johns Hopkins Medicine, and Malinka Walaliyadde, CEO of AKASA, will share everything healthcare leaders need to know about this innovative technology and how revenue cycles are taking advantage of it. You’ll learn about: 🤖 The evolution of GenAI 🧐 How leading health systems are evaluating this technology in the revenue cycle 📈 How GenAI can drive innovation and improve performance in prior authorization and beyond See you there!

💥 Meet AKASA Medical Coding: The first GenAI assistant for coders 💥 Earlier this spring, we introduced you to Authorization Advisor, the first in a suite of generative AI (GenAI) revenue cycle assistants. Today, we’re building on that effort. 🚀 AKASA Medical Coding™ is a new groundbreaking mid-cycle solution that puts the power of GenAI at medical coders’ fingertips, enabling them to work with unprecedented efficiency, accuracy, and comprehensiveness. The end result? More accurate coding, more efficient teams, and more appropriate revenue — all at a lower cost. Driven by our proprietary GenAI technology and trained on each health system’s clinical and financial data, AKASA Medical Coding: 📑 Reads every relevant clinical document for every encounter (clinical notes, imaging reports, clinical observations, and more) ✅ Identifies recommended codes 🧠 Provides justifications (linked to supporting medical text) for coders to accept or revise 📊 Shares AI confidence level indicators to make the approval process more efficient 💪 Addresses multiple service lines, within the most complex inpatient settings 📖 Combines clinical and EDI data to create a cohesive patient story Welcome to the next generation of medical coding technology. See AKASA Medical Coding in action: akasa.com/coding